View Older Stories View More Recent Stories
-
Hims & Hers Health, Inc. (HIMS) call put ratio 1 call to 1.5 puts with a focus on February 28 weekly puts
-
Hims and Hers (HIMS) PT Raised to $85 at BTIG
-
Hims & Hers Health, Inc. (HIMS) call put ratio 1 call to 1 put as share price up
-
Morgan Stanley Downgrades Hims and Hers (HIMS) to Equalweight
-
Hims & Hers Health, Inc. (HIMS) call put ratio 1 call to 1.1 puts with a focus on February 28 weekly 69 calls as share price up 3.9%
-
BofA Securities Reiterates Underperform Rating on Hims and Hers (HIMS), PT $18
-
Hims & Hers Health, Inc. (HIMS) call put ratio 1 call to 1 put as share price down 1.6%
-
Citi Downgrades Hims and Hers (HIMS) to Sell
-
This GLP-1 stock is likely to deliver a revenue beat: Jefferies
-
Jefferies Reiterates Hold Rating on Hims and Hers (HIMS), 'Data Points to Rev Beat in 4Q'
-
BTIG Starts Hims and Hers (HIMS) at Buy
-
Hims and Hers (HIMS) PT Raised to $31 at Needham, Top Pick for 2025 in Digital Health
-
Hims & Hers Health, Inc. (HIMS) call put ratio 1.4 calls to 1 put with focus on January 27.50 and 35 calls
-
Hims & Hers Health (HIMS) Quickly Falls 9% after FDA Says the Obesity Drug Shortage Ended
-
Hunterbrook Media is short Hims & Hers (HIMS)
-
Hims & Hers Health, Inc. (HIMS) call put ratio 1 call to 1.6 puts with focus on December 29 puts
-
Hims & Hers Health, Inc. (HIMS) option IV increases
-
Hims & Hers Health, Inc. (HIMS) call put ratio 2.2 calls to 1 puts with focus on December 32 calls
-
Hims & Hers Health, Inc. (HIMS) December IV bid on call put ratio 1.1 calls to 1 puts
-
Morgan Stanley Starts Hims and Hers (HIMS) at Overweight
-
Hims & Hers Health, Inc. (HIMS) option implied volatility near upper end of range
-
Hims & Hers Health, Inc. (HIMS) December option implied volatility elevated
-
Hims & Hers Health, Inc. (HIMS) falls 7% as Ro says it is working with Eli Lilly to streamline access to Zepbound
-
Hims & Hers Health, Inc. (HIMS) spreader active in December 21 and 26 puts
-
Hims and Hers (HIMS) PT Raised to $40 at Nephron, 'Increasing Subscriber Outlook & Target Price'
-
Hims and Hers (HIMS) PT Raised to $38 at Canaccord Genuity
-
Hims & Hers Health (HIMS) Mentioned as Long by Short Seller Hunterbrook
-
BofA Securities on Hims and Hers (HIMS): 'Trump’s FDA nominee currently works for a GLP-1 compounder'
-
Hims & Hers Health, Inc. (HIMS) Trades at High, Up 12%
-
Hims & Hers Health (HIMS) Expands Nutrition Support to Fuel Customers’ Weight Loss Journeys
-
Hims & Hers Health, Inc. (HIMS) call put ratio 1 call to 1.5 puts on active option volume of 101K contracts
-
Archegos Founder Bill Hwang Sentenced To 18 Years In Prison
-
TD Cowen Reiterates Buy Rating on Hims and Hers (HIMS)
-
Hims & Hers Health, Inc. (HIMS) call put ratio 1.1 calls to 1 put amid wide price movement
-
Hims & Hers Health, Inc. (HIMS) call put ratio 1.1 calls to 1 put as share price down 5.2%
-
Hims & Hers Health, Inc. (HIMS) options active on volume of 274K contracts
-
Hims & Hers Health, Inc. (HIMS) options active on 274K contracts amid wide price movement
-
BofA Securities Downgrades Hims and Hers (HIMS) to Underperform
-
Increasing unusual put option volume: ZETA IGV TGTX QXO HIMS INDA MT LUNR PAGS RKLB RITM
-
Hims & Hers Health, Inc. (HIMS) Weakness Tied to Amazon Telehealth Offering
-
Hims and Hers (HIMS) PT Raised to $21 at Piper Sandler
-
Hims and Hers (HIMS) PT Raised to $28 at Needham
-
TD Cowen Reiterates Buy Rating on Hims and Hers (HIMS)
-
Hims and Hers (HIMS) PT Raised to $24 at Citi
-
Truist Securities Reiterates Hold Rating on Hims and Hers (HIMS)
-
Hims and Hers (HIMS) PT Raised to $27 at BofA Securities
-
After-hours movers: Palantir, Cleveland-Cliffs, Coinbase and more
-
Hims & Hers Health, Inc. (HIMS) Tops Q3 EPS by 22c; beats on guidance
-
Hims & Hers Health, Inc. (HIMS) Falls 14%
-
Hims and Hers (HIMS) PT Raised to $26 at Leerink Partners

